← All Stocks
pharma

PFE — Pfizer Inc.

Conviction20
Congress 90d1
Insider 90d0
Markets2
Lobbying6
Contracts1
CountryUS

PFE

Pfizer Inc.

pharma
20thin · 1 src▼ Bearish1 source agree
🏛 Congress

Congressional trades

Last 90 days
0 buy1 sell1 legislator
  • sell Thomas H Tuberville$15K–$50K · Jun 8, 2026
All trades →

Prediction markets

Live odds

Lobbying filings

Last 2 years
  • FEDERAL HEALTH POLICY STRATEGIES$60K · 2026 first_quarter
    HCR
  • PFIZER INC.$4.4M · 2026 first_quarter
    CPTHCRMMMTRD
  • MARSHALL & POPP, LLC$60K · 2026 first_quarter
    CPTPHATAXTRD
  • ALTRIUS GROUP, LLC— · 2026 first_quarter
  • THE WASHINGTON TAX & PUBLIC POLICY GROUP$110K · 2026 first_quarter
    TAX
  • BGR GOVERNMENT AFFAIRS— · 2026 first_quarter
    HCR

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States67/100
Posture: neutralView United States →

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$68.4M · 0% defense
  • Department of Health and Human Services$68.4M · Sep 15, 2015
v·ebea842